Subscribe to stay informed!
A Berwyn-based biopharmaceutical company is entering an agreement to evaluate a candidate for treating rare pediatric epilepsy, writes John George for the Philadelphia Business…
Before we send you to this site, please subscribe to our daily newsletter.